Bioline Rx Ltd Adr (BLRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Perché BLRX Giù? Forum Previsione Frazionamento azionario

Perché le azioni Bioline Rx Ltd Adr (BLRX) sono in ribasso?

Abbiamo notato un calo di 40.71% nelle azioni di Bioline Rx Ltd Adr (BLRX) durante la sessione di negoziazione di 2024-11-21. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!

2023-11-20:

Shares of BioLineRx (BLRX) dropped by 10.59% from $1.700 to $1.520 in the trading on Monday, November 20, 2023. The reason why BLRX is down today is due to the company's disappointing Q3 financial results.

Research and development expenses decreased by 37.6%, mainly due to reduced costs associated with NDA supporting activities and the completed AGI-134 clinical trial.
Sales and marketing expenses saw a significant 517.4% increase, driven by heightened pre-commercialization activities.
General and administrative expenses rose by 7.7% due to minor increases in various G&A expenses.
Non-operating expenses surged, primarily due to the revaluation of outstanding warrants caused by an increase in the company's share price.
Net losses for both the three and nine months ended September 30, 2023, were significantly higher compared to the same periods in 2022.

INCY

$70.39

0.93%

SMMT

$18.42

1.07%

MRNA

$38.25

3.55%

UTHR

$367.36

0.83%

BGNE

$194.56

0.15%

BNTX

$108.23

5.96%

Bioline Rx Ltd Adr (BLRX)

Perché le azioni Bioline Rx Ltd Adr (BLRX) sono in ribasso?

Simile a BLRX